28th week of 2010 patent applcation highlights part 29 |
Patent application number | Title | Published |
20100178214 | Glass Microfluidic Devices and Methods of Manufacture Thereof - A micro fluidic device ( | 2010-07-15 |
20100178215 | Exhaust Gas Purification Apparatus - An exhaust gas purification apparatus in which layout restriction is lessened to be able to further achieve space-saving is proposed. The exhaust gas purification apparatus includes a first cylindrical housing in which an oxidation catalytic converter and a PM collection filter are contained and a second cylindrical housing in which a reducing catalytic converter and an ammonia oxidation catalytic converter are contained. The exhaust gas purification apparatus further includes a communicating pipe that connects between far end portions of both the housings, and a nozzle that is disposed in the communicating pipe and injects liquid reducing agent in exhaust gas. The two housings are closely disposed such that axis lines thereof are arranged substantially parallel. The communicating pipe is disposed such that an axis line thereof is arranged substantially parallel with the axis lines of the housings. A flow passage of the exhaust gas from the first housing through the communicating pipe to the second housing is formed into a substantial N-shape. | 2010-07-15 |
20100178216 | Exhaust Gas Purification Apparatus - An exhaust gas purification apparatus in which layout restriction is lessened to be able to further achieve space-saving is proposed. The exhaust gas purification apparatus includes a first cylindrical housing in which an oxidation catalytic converter and a PM collection filter are contained and a second cylindrical housing in which a reducing catalytic converter and an ammonia oxidation catalytic converter are contained. The exhaust gas purification apparatus further includes a communicating pipe that connects between far end portions of both the housings, and a nozzle that is disposed in the communicating pipe and injects liquid reducing agent in exhaust gas. The two housings are closely disposed such that axis lines thereof are arranged substantially parallel. The communicating pipe is disposed such that an axis line thereof is arranged substantially parallel with the axis lines of the housings. A flow passage of the exhaust gas from the first housing to the second housing is folded by the communicating pipe. | 2010-07-15 |
20100178217 | System and Method For Providing An Integrated Reactor - A system and method for providing an integrated indirectly fired reactor and steam generator are disclosed. According to one embodiment, the reactor comprises an indirect heating zone heating water and generating steam, a mixing zone mixing feedstock and the steam and providing a mixture of the feedstock and the steam, and a reaction zone comprising a first reactor and a second reactor. The first reactor converts the mixture to a first syngas at a first temperature. The second reactor converts the first syngas to a second syngas at a second temperature, the second temperature being higher than the first temperature. | 2010-07-15 |
20100178218 | METAL ALKOXIDES, APPARATUS FOR MANUFACTURING METAL ALKOXIDES, RELATED METHODS AND USES THEREOF - Compounds, synthesis of, and methods for synthesizing metal alkoxide derivatives; and metal alkoxide derivatives for use as flame retardants are described. Group 13 metal alkoxides having flame retardant properties may be prepared by reacting the group 13 metal trihydroxide with an alcohol. | 2010-07-15 |
20100178219 | HIGHLY HEAT INTEGRATED REFORMER FOR HYDROGEN PRODUCTION - Described herein is a highly heat integrated steam reformer/combustor assembly that can be used in a fuel processor for hydrogen production from a fuel source. The assembly comprises a reforming section and a combustion section separated by a wall. Catalyst able to induce the reforming reactions is coated on the wall facing the reforming section. Catalyst able to induce the combustion reactions is coated on the wall facing the combustion section. A steam and fuel mixture is supplied to the reforming section where it is reformed to product hydrogen. A fuel and air mixture is supplied to the combustion section where it is combusted to supply the heat for the reformer. Catalytic combustion takes place on the combustion catalyst coated on one side of the wall while catalytic reforming takes place on the reforming catalyst coated on the other side of the wall. Heat transfer is very facile and efficient across the wall. Multiple such assemblies can be bundled to form reactors of any size. | 2010-07-15 |
20100178220 | METAL ALKOXIDES, APPARATUS FOR MANUFACTURING METAL ALKOXIDES, RELATED METHODS AND USES THEREOF - Compounds, synthesis of, and methods for synthesizing metal alkoxide derivatives; and metal alkoxide derivatives for use as flame retardants are described. Group 13 metal alkoxides having flame retardant properties may be prepared by reacting the group 13 metal trihydroxide with an alcohol. | 2010-07-15 |
20100178221 | REACTOR AND METHOD FOR MANUFACTURING REACTOR - It is aimed to promote further integration of channels in a reactor. | 2010-07-15 |
20100178222 | MICRO-PASSAGE CHIP - Means for overcoming the problems which the conventional glass microchannel chips have are disclosed. That is, a microchannel chip in which microchannels can be formed at a low cost, and which has a high chemical resistance is disclosed. The microchannel chip is constituted by a substrate made of carbon, which has a channel in its surface; and a cover composed of a glass plate bonded to the substrate. The cover is bonded to the substrate by heating at least a part of the contact surface at which the substrate is in contact with the cover. | 2010-07-15 |
20100178223 | (Roberts) plasma waterbath - A water bath in which a process of agitation is used. The blood, blood product, or any product that is thawed at or needs to remain heated at 25-40 degrees Celsius is used. | 2010-07-15 |
20100178224 | LEAN NOx TRAP/CONVERSION CATALYST - A process and composition for converting nitrogen oxides present in exhaust gases produced by an internal combustion engine utilize cobalt and at least one alkali metal or alkaline earth metal as a component of an adsorbent. The process involves contacting the exhaust gas with an adsorbent which adsorbs the nitrogen oxides in lean-burn conditions and recurrently reducing the oxygen concentration of the exhaust gas. During such periods of reduced oxygen concentration, the nitrogen oxides are then desorbed and reduced to nitrogen, thereby reducing the concentration of the nitrogen oxides in the exhaust gas. The composition of the adsorbent comprises an oxide support and at least two components loaded on the support and containing cobalt and at least one alkali metal or alkaline earth metal. The composition demonstrates improved activity at higher temperatures and improved thermal stability. | 2010-07-15 |
20100178225 | METHOD FOR TREATMENT OF A GAS STREAM CONTAINING SILICON TETRAFLUORIDE AND HYDROGEN CHLORIDE - The present invention is directed to a method for treatment of a gas stream comprising silicon tetrafluoride and hydrogen chloride. For example, the present invention is directed to a method for treatment of such a gas stream that involves contacting the gas stream with a metal that reacts with the hydrogen chloride to provide a treated gas stream having reduced hydrogen chloride content. The present invention is further directed to methods for subjecting silicon tetrafluoride and hydrogen chloride-containing gas streams to elevated pressure to provide gas streams suitable for transport. | 2010-07-15 |
20100178226 | Method for removing methane for gas mixtures - The invention relates to a method for oxidizing methane, including passing a gaseous, methane-containing mixture over a catalyst, wherein a carrier with a substrate surface consists substantially of titanium dioxide with a combination of platinum and palladium thereon, in the presence of molecular oxygen, and to a catalyst suitable thereto. | 2010-07-15 |
20100178227 | METHOD FOR PREPARING METAL COMPOUND NANOPARTICLES - A method for preparing metal compound nanoparticles, comprising treating a uniform dispersion of at least one metal precursor in an organic solvent with a supercritical carbon dioxide fluid to attain a homogeneous mixture, which is subjected to a solvothermal reaction under a subcritical CO | 2010-07-15 |
20100178228 | Synthesis of M2B12H12 - A method for preparing M | 2010-07-15 |
20100178229 | ELEMENTAL SOLVENTS - Use of ionic liquids as solvents for elements such as phosphorus, selenium, tellurium and sulphur, and compounds thereof. | 2010-07-15 |
20100178230 | Apparatus And Method For Manufacturing Trichlorosilane And Method For Manufacturing Polycrystalline Silicon - A method of manufacturing trichlorosilane includes a conversion reaction process (first reaction process) for producing a first reaction product gas, which contains trichlorosilane, dichlorosilylene, hydrogen chloride, and high-order silane compounds, by performing a conversion reaction of silicon tetrachloride and hydrogen, which are raw materials, in a first temperature range that is equal to or higher than 1000° C. and equal to or lower than 1900° C.; a first cooling process for cooling the first reaction product gas to a temperature of 950° C. or lower within 1 sec (except that the first reaction product gas is cooled to a temperature lower than 600° C. within 0.01 sec); a second reaction process for maintaining the temperature of the first reaction product gas in a second temperature range, which is equal to or higher than 600° C. and equal to or lower than 950° C., during the time that is equal to or more than 0.01 sec and equal to or less than 5 sec; and a second cooling process for cooling a second reaction product gas, which has been subjected to the second reaction process, to a temperature lower than 600° C. | 2010-07-15 |
20100178231 | Method of Sequestering Carbon Dioxide - The invention provides a method for sequestering carbon dioxide. The method comprises cutting organic material into chips, carbonising the chips of organic material by applying microwave energy and storing the resulting charcoal in a carbon sink. | 2010-07-15 |
20100178232 | PROCESS FOR REMEDIATION OF PLASTIC WASTE - A single step process for degrading plastic waste by converting the plastic waste into carbonaceous products via thermal decomposition of the plastic waste by placing the plastic waste into a reactor, heating the plastic waste under an inert or air atmosphere until the temperature of 700° C. is achieved, allowing the reactor to cool down, and recovering the resulting decomposition products therefrom. The decomposition products that this process yields are carbonaceous materials, and more specifically egg-shaped and spherical-shaped solid carbons. Additionally, in the presence of a transition metal compound, this thermal decomposition process produces multi-walled carbon nanotubes. | 2010-07-15 |
20100178233 | SYNTHETIC DIAMONDS PREPARED FROM ORGANIC MATERIALS - The present invention relates to a method of making a more permanent remembrance from a graphitizable or carbon-containing material, wherein the material is part of or embodied in an ephemeral object that signifies a power, attribute, memory, custom, tradition, emotion or symbolism associated with a life experience or event. The method includes transforming the ephemeral object to the more permanent remembrance by converting the carbon-containing material to a synthetic diamond, thus transferring the power, attribute, memory, custom, tradition, emotion or symbolism of the object or the associated life experience or event into the diamond. The synthetic diamond can be prepared by transforming the carbon-containing material to a carbon compound or carbon-containing compound; and then converting the carbon compound or carbon-containing compound into the synthetic diamond. | 2010-07-15 |
20100178234 | Multilayer substrate and method for producing the same, diamond film and method for producing the same - The present invention is a multilayer substrate comprising, at least, a single crystal substrate, a diamond film vapor-deposited on the single crystal substrate, wherein the single crystal substrate is a single crystal Ir or a single crystal Rh and a method for producing a multilayer substrate comprising, at least, a step of vapor-depositing a diamond film on a single crystal substrate, wherein a single crystal Ir or a single crystal Rh is used as the single crystal substrate. As a result, there is provided a multilayer substrate having a high quality single crystal diamond film with a large area and with a high crystallinity as a continuous film in which the diamond and the single crystal substrate are not broken and a method for producing the multilayer substrate at low cost. | 2010-07-15 |
20100178235 | METHOD OF PRODUCING STABLE OXY-CHLORO ACID - The invention is a method of producing stable chlorous acid for use as a cleaning agent and biocidal composition. The method passes a salt of an oxy-chloro acid over a resin to allow for an ion exchange that produced the oxy-chloro acid. The invention allows for the production of a stable chlorous acid that can be used as a biocidal agent and a cleaning agent without the effect on many surfaces or membranes as normal oxy-chloro compositions. | 2010-07-15 |
20100178236 | Sulfur Collection Systems and Processes with Integrated Degassing - Systems and methods for the collection of liquid sulfur with integrated degassing are described, wherein the system and methods include the use of one or more liquid jet pumps or eductors employing a pumped liquid sulfur recycle stream as motive fluid to boost sulfur rundown pressure. The new invention eliminates piping constraints inherent with conventional gravity flow, thus permitting location of the sulfur collection vessel above ground and remote from the sulfur recovery unit. In addition, the described methods provide entrainment and enough agitation in the liquid sulfur such that simultaneously degassing occurs within the sulfur collection piping and associated systems described herein. The instant systems and methods are integrated with the degassing system, meaning that the sulfur will be initially degassed during the collection process, and then further degassing occurs by the methods described herein. | 2010-07-15 |
20100178237 | PROCESS FOR RECOVERY OF WATER ISOTOPOLOGUES - Disclosed is a process and a system for recovery of isotopologues of water from an aqueous vapour stream optionally containing acidic gases. | 2010-07-15 |
20100178238 | Method and Apparatus for Hydrocarbon Reforming Based On Oxygen-Permeable Membrane - [Objects] To provide a method and an apparatus for reforming a hydrocarbon with a prolonged life of an oxygen-permeable membrane and a high recovery rate. | 2010-07-15 |
20100178239 | Process for converting carbon dioxide from coal utilization to a solid ash - A process for conversion of coal in a reaction vessel comprises steps of: admixing coal and powdered alumina clay to form reactants; injecting the reactants with a high-pressure steam jet into the reaction vessel; and producing aluminum oxalate ash and hydrogen. Preferably, the reaction vessel is pressurized to maximize the production of aluminum oxalate and hydrogen. Optionally, the process includes adding calcium carbonate if not present in the clay. The reactants in the reaction vessel are typically maintained a temperature of about 2,000 degrees Kelvin and a pressure of about 1 mega Pascals. To save energy, the process may include preheating water with the aluminum oxalate ash to aid in creating pressurized steam. The hydrogen may be mixed with air and burned in a combustion chamber, such as is found within a gas turbine-generator unit to produce electricity. Optionally the reactants may include an aqueous sodium hydroxide. | 2010-07-15 |
20100178240 | CATALYTIC SYSTEM FOR GENERATING HYDROGEN BY THE HYDROLYSIS REACTION OF METAL BOROHYDRIDES - Catalytic system comprising at least two components:
| 2010-07-15 |
20100178241 | NOVEL PROCESS FOR PREPARING EU-1 ZEOLITE - The invention concerns a process for preparing an EU-1 zeolite having a XO | 2010-07-15 |
20100178242 | LABELLING METHODS - The invention provides a method for radiofluorination of biological vectors such as peptides comprising reaction of a compound of formula (II): or a salt thereof with a source of [ | 2010-07-15 |
20100178243 | Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system - The present invention relates to a method of stabilizing a low molecular weight compound in a cationic liposome, wherein said compound has a low solubility in a lipid membrane and/or a low permeability across a lipid membrane. Preferrably, the compound is modified in order to increase lipid membrane solubility and/or lipid membrane permeability. After delivery of the cationic liposome to a target site, particularly a target site in an organism, the modification is reversed and the low molecular weight compound may enact its desired activity. | 2010-07-15 |
20100178244 | Biocompatible Microbubbles to Deliver Radioactive Compounds to Tumors, Atherosclerotic Plaques, Joints and Other Targeted Sites - A composition and method for targeted use of radionuclide therapy for the treatment of cancer and cancerous tumors, atherosclerotic plaques, joints and other targeted sites. Microparticles, microbubbles, or nanoparticles deliver therapeutic doses of radiation, included radiation from alpha emitting radionuclides, to sites in a patient. The delivery may be targeted by targeting agents linked to the microparticles, microbubbles, or nanoparticles or by the external application of energy, or both. | 2010-07-15 |
20100178245 | Biocompatible Microbubbles to Deliver Radioactive Compounds to Tumors, Atherosclerotic Plaques, Joints and Other Targeted Sites - A composition and method for targeted use of radionuclide therapy for the treatment of cancer and cancerous tumors, atherosclerotic plaques, joints and other targeted sites. Microparticles, microbubbles, or nanoparticles deliver therapeutic doses of radiation, included radiation from alpha emitting radionuclides, to sites in a patient. The delivery may be targeted by targeting agents linked to the microparticles, microbubbles, or nanoparticles or by the external application of energy, or both. | 2010-07-15 |
20100178246 | TECHNETIUM- AND RHENIUM-BIS(HETEROARYL) COMPLEXES AND METHODS OF USE THEREOF FOR INHIBITING PSMA - A compound of Formula I, a pharmaceutically acceptable salt, or solvate thereof: | 2010-07-15 |
20100178247 | CA-IX SPECIFIC RADIOPHARMACEUTICALS FOR THE TREATMENT AND IMAGING OF CANCER - A compound that recognizes and binds to the CA-IX protein has Formula I, II, III, or IV. The compounds may include a radioactive element for radioimaging or therapeutic applications. Thus, pharmaceutical compositions may be prepared with one or more of the compounds of Formula I, II, III, or IV. | 2010-07-15 |
20100178248 | USE OF PHENYLOXYANILINE DERIVATIVES FOR IMAGING CARDIOVASCULAR DISEASES - The present invention relates to the use of a specific compound, as described in detail below, having a high affinity to the peripheral benzodiazepine receptor for imaging cardiac and cardiovascular diseases for which inflammation and/or mitochondrial dysfunction and any other pathophysiological process leading to PBR activation are major contributing factor. | 2010-07-15 |
20100178249 | IMAGING MEDIUM COMPRISING LACTATE AND HYPERPOLARISED 13C-PYRUVATE - The invention relates to an imaging medium containing lactate and hyperpolarised | 2010-07-15 |
20100178250 | Method of Local Delivery of Bioactive and Diagnostic Agents Using Magnetizable Bone Cement - A method of making a magnetizable implant, the method includes mixing a curable matrix and the at least one of the bioactive agent or the diagnostic agent associated with the magnetizable carrier to form a magnetizable curable matrix; implanting the magnetizable curable matrix in a cavity in a body of a mammal whereby the magnetizable curable matrix takes on a shape of the cavity and forms a molded magnetizable curable matrix; simultaneously curing the molded magnetizable curable matrix and applying the magnetic field and thereby causing the at least one of the bioactive agent or the diagnostic agent associated with a magnetizable carrier to move and arrange within the molded magnetizable curable matrix at or near an interface between the cavity and an outer surface of the molded magnetizable curable bioactive matrix. | 2010-07-15 |
20100178251 | Dual-Sensitizer-Containing Luminescent Compounds, Conjugates, and Uses Thereof - The invention relates to novel luminescent compositions of matter containing two fluorophores (sensitizers), synthetic methods for making the compositions, macromolecular conjugates of the compositions, and the use of the compositions and their conjugates in various methods of detection. The invention also provides kits containing the compositions and their conjugates for use in the methods of detection. | 2010-07-15 |
20100178252 | PRODUCTS AND METHODS FOR DISCLOSING CONDITIONS IN THE ORAL CAVITY - An oral composition capable of identifying a condition within the oral cavity by causing a visual contrast between the condition and the hard and soft tissues of the oral cavity has at least one disclosing agent. The disclosing agent can fluoresce in order to highlight conditions within the oral cavity. | 2010-07-15 |
20100178253 | PEPTIDE IMAGING AGENTS - The present invention relates to labelled cMet binding peptides suitable for optical imaging in vivo. The peptides are labelled with a benzopyrylium dye suitable for imaging in the red to near-infrared region. Also disclosed are pharmaceutical compositions and kits, as well as in vivo imaging methods, especially of use in the detection, staging, diagnosis, monitoring of disease progression or monitoring of treatment of colorectal cancer (CRC). | 2010-07-15 |
20100178254 | UNIT ASSEMBLY FOR MULTIPLE FILM DOSAGES, APPARATUS, AND METHODS - A unit assembly including a plurality of individual film strips, each film strip having an active within a polymer matrix, the film strips having respective perimetrical edges, the plurality of individual film strips being alternatingly positioned next to one another such that a film strip perimetrical edge is at least partially offset from a subsequent film strip perimetrical edge, wherein the respective perimetrical edges of the film strips are directly adjacent to each other. | 2010-07-15 |
20100178255 | Composition and method to treat otitis media and ventilator- associated pneumonia - A composition and method for prevention and treatment of otitis media and ventilator-associated pneumonia are described. The composition is made with GTase inhibitory polyphenol and polyhydric alcohol carrier. The composition is topical for intra-oral and otic use. | 2010-07-15 |
20100178256 | ORAL ANTI-ODOR COMPOSITIONS - The invention is directed to the use of a composition comprising a higher alcohol selected from 1-nonanol, 1-decanol and 1-undecanol, or mixtures thereof and taste-masking additives, as an oral anti-odor preparation. The invention further provides anti-odor toothpaste, mouthwash, candies and other anti-odor preparations for oral use. | 2010-07-15 |
20100178257 | BLOCK POLYMER, COSMETIC COMPOSITION COMPRISING IT AND COSMETIC TREATMENT PROCESS - A block polymer containing, in a block with a Tg of less than 20° C., at least one monomer of formula (I): | 2010-07-15 |
20100178258 | COMPOSITION AND METHOD FOR THE TREATEMENT OF SKIN IRRITATIONS - A composition is provided that is suitable for topical administration for the treatment of a skin irritation, the composition comprising acetylsalicylic acid and sodium bicarbonate. Also provided is a method for treating a skin irritation in an individual comprising topically administering to the affected area a therapeutically effective amount of a composition comprising acetylsalicylic acid and sodium bicarbonate. The composition is particularly useful for decreasing the temperature at the surface of a sunburn and for reducing pain and discomfort caused by a sunburn. | 2010-07-15 |
20100178259 | REDUCING FIBROSIS USING MATRIX METALLOPROTEINASE INHIBITORS - Methods and compositions to prevent scarring of the skin include a matrix metalloproteinase inhibitor and a vehicle suitable for topical application. Scarring and damage to the epidermis and extracellular matrix may be reduced and/or prevented. Following skin damage, application of the matrix metalloproteinase inhibitor reduces expansion of the extracellular matrix portion of the skin compared to untreated skin. | 2010-07-15 |
20100178260 | COMPOSITION COMPRISING A RETINOID, AN ADENOSINE-BASED NONPHOSPHATED COMPOUND, AND A SEMICRYSTALLINE POLYMER - Composition containing, in a physiologically acceptable medium, at least one retinoid or a derivative thereof, one adenosine-based nonphosphated compound, and one semicrystalline polymer with one or more crystallizable side chain(s). Use for preventing and/or treating the cutaneous signs of ageing. | 2010-07-15 |
20100178261 | Cationic Cassia Derivatives and Applications Therefor - This invention relates to cationically derivatized polycalactomannans obtained from | 2010-07-15 |
20100178262 | NAIL VARNISH COMPRISING A DRYING OIL, A FILM-FORMING POLYMER AND A METAL SALT - A subject-matter of the present invention is a nail varnish, characterized in that it comprises at least one drying oil, at least one film-forming polymer and at least one metal salt. | 2010-07-15 |
20100178263 | PROCESS FOR LIGHTENING KERATIN MATERIALS USING AN ANHYDROUS COMPOSITION COMPRISING AT LEAST ONE FATTY SUBSTANCE AND AT LEAST ONE ALKALINE AGENT, AND AT LEAST ONE OXIDIZING COMPOSITION - The present disclosure relates to a process for lightening keratin fibers, comprising applying to the keratin fibers: an anhydrous composition (A) comprising at least one fatty substance in an amount of at least 20% by weight relative to the total weight of the composition, at least one surfactant, and at least one alkaline agent chosen from organic amines, organic amine salts, and ammonium salts; and a composition (B) comprising at least one oxidizing agent. The present disclosure also relates to a multi-compartment device comprising: a first compartment comprising the anhydrous composition (A); and a second compartment comprising the composition (B). | 2010-07-15 |
20100178264 | PROCESS FOR LIGHTENING OR PROCESS FOR DIRECT DYEING OR OXIDATION DYEING OF KERATIN FIBERS IN THE PRESENCE OF AT LEAST ONE AMMONIUM SALT AND DEVICE THEREFOR - The present disclosure relates to a process for lightening or dyeing keratin fibers, for example, human keratin fibers such as the hair, comprising applying to the keratin fibers: (a) an anhydrous cosmetic composition (A) comprising at least one fatty substance and at least one surfactant; (b) a cosmetic composition (B) comprising at least one ammonium salt; and (c) a composition (C) comprising at least one oxidizing agent; when the process is a process for dyeing keratin fibers, said cosmetic composition (B) further comprises at least one oxidation dye and/or at least one direct dye. The present disclosure also relates to a multi-compartment device comprising the disclosed compositions for lightening or dyeing keratin fibers. | 2010-07-15 |
20100178265 | HAIR CONDITIONING COMPOSITION - The present invention is related to a conditioning composition for hair comprising flavone derivatives and particularly on enhanced deposition of flavone derivatives onto hair. Accordingly, the compositions comprise at least one conditioning agent, at least one organic solvent, at least one flavone derivative and at least one hydroxycarboxylic and/or dicarboxylic acid and has a pH below 4.5. The conditioning composition of the present invention can be in the form of a shampoo, cleansing-conditioning composition, or in the form of a conditioner used after washing hair with cleansing compositions. | 2010-07-15 |
20100178266 | Process For The Manufacture Of Polyorganosiloxanes Comprising (C6-C60)-Alkylmethylsiloxy Groups And Dimethylsiloxy Groups - The present invention relates to novel processes for the manufacture of poly-organosiloxanes comprising (C6-C60)-alkylmethylsiloxy-groups and dimethyl-siloxy groups, polyorganosiloxanes obtainable by such processes, preferably aqueous emulsions comprising such polyorganosiloxanes and the use of such polyorganosiloxanes. | 2010-07-15 |
20100178267 | BETA-AMINO ESTER COMPOUNDS AND USES THEREOF - Hair treatment compositions are disclosed comprising a β-amino ester compound in a cosmetically acceptable vehicle, such as a spray or cream. In embodiments, the compounds include a polybutadiene moiety. Methods of treating hair with the compositions to impart volume, texture and definition are also disclosed. | 2010-07-15 |
20100178268 | BIOCIDIC PACKAGING FOR COSMETICS AND FOODSTUFFS - The present invention presents a biocidic packaging for cosmetics and/or foodstuffs, comprises at least one insoluble proton sink or source (PSS). The packaging is provided useful for killing living target cells (LTCs), or otherwise disrupting vital intracellular processes and/or intercellular interactions of said LTC upon contact. The PSS comprises, inter alia, (i) proton source or sink providing a buffering capacity; and (ii) means providing proton conductivity and/or electrical potential. The PSS is effectively disrupting the pH homeostasis and/or electrical balance within the confined volume of the LTC and/or disrupting vital intercellular interactions of the LTCs while efficiently preserving the pH of said LTCs' environment. The present invention also discloses a method for killing living target cells (LTCs), or otherwise disrupting vital intracellular processes and/or intercellular interactions of said LTC being in a packaging, especially cosmetic or foodstuffs' packaging. | 2010-07-15 |
20100178269 | Compositions and Methods for the Treatment of Heart Failure - The invention provides a therapeutic composition comprising an aqueous buffer, and a therapeutic agent that improves the functioning of a diseased heart by decreasing left ventricular end-diastolic pressure and simultaneously increasing left ventricular ejection without affecting the blood pressure or heart rate. | 2010-07-15 |
20100178270 | METAL SALT NANOGEL-CONTAINING POLYMERS - The invention relates to a method for producing metal salt nanogel-containing aqueous dispersions, solid intermediate products and waterproof plastic products, thus allowing the simple production of novel products having homogeneously distributed agents, which exhibit, for example, an antimicrobial or barrier effect and/or have an absorbing capacity, such as with respect to oxygen, humidity, chemical, particularly gaseous compounds, or electromagnetic or radioactive radiation. | 2010-07-15 |
20100178271 | Combination Therapy - Methods to mobilize progenitor and/or stem cells from the bone marrow to the bloodstream by administering a combination of at least one CXCR | 2010-07-15 |
20100178272 | STRUCTURE AND USE OF 5'PHOSPHATE OLIGONUCLEOTIDES - Oligonucleotides bearing free, uncapped 5′ phosphate group(s) are recognized by RIG-I, leading to the induction of type I IFN, IL-18 and IL-1β production. Bacterial RNA also induces type I IFN production. 5′ phosphate oligonucleotides and bacterial RNA can be used for inducing an anti-viral response or an anti-bacterial response, in particular, type I IFN and/or IL-18 and/or IL-1β production, in vitro and in vivo and for treating various disorders and diseases such as viral infections, bacterial infections, parasitic infections, tumors, allergies, autoimmune diseases, immunodeficiencies and immunosuppression. Single-stranded 5′ triphosphate RNA can be used for inducing an anti-viral response, an anti-bacterial response, or an anti-tumor response, in particular, type I IFN and/or IL-18 and/or IL-1β production, in a target cell-specific manner. | 2010-07-15 |
20100178273 | METHODS AND COMPOSITIONS FOR TREATING MUCOSITIS - The invention relates generally to the field of mucositis. More particularly, the present invention relates to methods and compositions for treating and preventing mucositis. In particular for treating or preventing oral mucositis, especially stomatitis and esophagitis. The invention generally relates to the use of recombinant non-pathogenic and non-invasive microorganisms, in particular recombinant bacterium or yeast expressing a trefoil peptide in particular in combination with one or more factors that target the mucus, tight junctions or extracellular matrix and/or factors typically used in the treatment of mucositis. | 2010-07-15 |
20100178274 | APPLICATION OF SYNOVIUM-DERIVED MESENCHYMAL STEM CELLS (MSCS) FOR CARTILAGE OR MENISCUS REGENERATION - An object of the present invention is to provide a method for treating defects of articular cartilage or meniscus of a patient using in vivo chondrogenesis of synovium-derived MSCs. The present invention provides a method for treating a disease associated with defects of cartilage or meniscus. In the present invention, the method for treating a disease associated with defects of cartilage or meniscus comprises the following steps: culturing ex vivo autologous synovium-derived mesenchymal stem cells (MSCs); implanting the MSCs such that said cartilage defect site or meniscal defect site is covered by the MSCs; and regenerating cartilage tissue at the cartilage defect site or meniscal defect site in situ by differentiating the MSCs into cartilage cells. | 2010-07-15 |
20100178275 | METHODS AND MEANS FOR STEM CELL PROLIFERATION AND SUBSEQUENT GENERATION AND EXPANSION OF PROGENITOR CELLS, AS WELL AS PRODUCTION OF EFFECTOR CELLS AS CLINICAL THERAPEUTICS - The invention is related to methods for expanding and differentiating hemopoietic progenitor cells in a medium comprising a collection of cytokines, desulphated glycosaminoglycan and human serum. The invention further relates to a collection of cells obtainable by a method of the invention, use of the collection of cells, and a kit of parts for expanding and differentiating hemopoietic progenitor cells. | 2010-07-15 |
20100178276 | CONSTITUTIVE EXPRESSION OF COSTIMULATORY LIGANDS ON ADOPTIVELY TRANSFERRED T LYMPHOCYTES - The present invention provides immunoresponsive cells, including T cells, cytotoxic T cells, regulatory T cells, and Natural Killer (NK) cells, expressing at least one of an antigen-recognizing receptor and a co-stimulatory ligand and methods of use therefore for the treatment of neoplasia and other pathologies where an increase in an antigen-specific immune response is desired. | 2010-07-15 |
20100178277 | METHODS AND COMPOSITIONS FOR STIMULATING CELLS - The invention provides compositions and methods for treating, preventing, delaying the onset, and/or delaying the development of a disease or condition for which the activation, differentiation, and/or proliferation of one or more cell types is beneficial. These compositions and methods include, for example, a hydrogenated pyrido[4,3-b]indole such as dimebon and/or a cell that has been incubated with a hydrogenated pyrido[4,3-b]indole such as dimebon. In some embodiments, the compositions and methods also include a growth factor and/or an anti-cell death compound. The invention also provides methods of activating a cell, promoting the differentiation of a cell, and/or promoting the proliferation of a cell by incubating the cell with one or more hydrogenated pyrido[4,3-b]indoles or pharmaceutically acceptable salts thereof. In some embodiments, the cell is also incubated with one or more growth factors and/or anti-cell death compounds. | 2010-07-15 |
20100178278 | FORMABLE BIOCERAMICS - A formable bioceramic including hydroxyapatite nanocrystals, gelatin, and sol-gel-containing material is described. Also described is a process for making and using the bioceramic. The formable bioceramic displays superior mechanical strength, elasticity, biocompatibility and forming capabilities and is targeted for bone repairs and template-assisted tissue engineering applications. | 2010-07-15 |
20100178279 | Beta-Glucan Enhances Hematopoietic Progenitor Cells Engraftment and Promotes Recovery from Chemotoxicity - Methods to use beta glucans in the culture of cell populations containing CD34+ cells in order to expand the numbers of CD34+ subsets of progenitor and stem cells are provided. Methods to improve homing and engraftment of stem and progenitor cells by first culturing the cells with beta glucans, or co-administering with beta glucans, are also provided. Additionally, methods to ameliorate chemotherapy toxicity and promote development of functionally active neutrophils by administering beta glucans are presented. The beta glucans are preferably extracted from maitake mushroom ( | 2010-07-15 |
20100178280 | USE OF SIRT7 FOR TREATING AGE-RELATED DISEASES - The present invention relates to a pharmaceutical composition comprising (i) a nucleic acid molecule encoding a protein having Sirt7 function wherein said nucleic acid molecule (a) has the sequence of SEQ ID NO: 1, 3, 5 or 7; (b) encodes a protein having the sequence of SEQ ID NO: 2, 4, 6 or 8; (c) hybridizes under stringent conditions to the molecule of (a) or (b); or (d) has an identity on the nucleic acid level of at least 80% with the molecule of (a), (b) or (c); (ii) a vector comprising the nucleic acid molecule of (i); (iii) a host cell comprising the vector of (ii); or (iv) a protein encoded by the nucleic acid molecule of (i). The pharmaceutical composition is used for example in the treatment of age-related diseases. Furthermore, the invention relates to screening methods for the identification of compounds useful in the treatment of age-related diseases. | 2010-07-15 |
20100178281 | SUPPLEMENTION OF MATERNAL DIET - The use of probiotic bacteria in the manufacture of a composition for administration to a woman in at least the third trimester of pregnancy for prevention of gestational diabetes, normalising plasma glucose concentration and/or increasing insulin sensitivity. | 2010-07-15 |
20100178282 | COMPOUNDS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF AMYLOID ASSOCIATED DISEASES - The invention is in general directed to compounds and methods for diagnosing, preventing or alleviating the symptoms of amyloid-associated diseases, for example, neuronal diseases, such as, for example, Alzheimer's disease, methods of screening for compounds useful in preventing or alleviating the symptoms of amyloid-associated diseases, methods of diagnostic imaging of A-beta fibrils, and compounds and methods useful for studying normal or disease-associated cellular mechanisms relating to amyloid proteins. | 2010-07-15 |
20100178283 | HYPOXIA RELATED GENES AND PROTEINS FOR THE TREATMENT AND DIAGNOSIS OF PREGNANCY RELATED COMPLICATIONS - The invention features methods for diagnosing and treating pregnancy related complications. The invention also features methods for identifying compounds useful for treating pregnancy related complications. | 2010-07-15 |
20100178284 | Composition for the Skin, Specifically for Inhibiting Ingrown Hair - A crème for use in connection with the treatment and prevention of ingrown hair. The crème basically comprises a carrier, preferably water and an active amount of encapsulated bromelain, the encapsulated bromelain preferably comprising an inert silicone, preferably cyclomethicone. Other components can be added to the composition, for example, beeswax, sunflower seed oil, shea butter and/or Tea Tree oil. The crème can be used to treat acne, as well. | 2010-07-15 |
20100178285 | SYNERGISTIC ANTHELMINTIC COMPOSITION - The present invention discloses novel synergistic anthelmintic compositions used for prevention and treatment of gastrointestinal nematodes comprising combination of therapeutically effective amount of ginger extract with proteolytic enzyme and fibre degrading enzymes. The novel anthelmintic compositions provide synergistic effect at comparatively lower doses which are affordable and impart minimal/no side effect on general health as well as milk yield of dairy animals. | 2010-07-15 |
20100178286 | METHODS AND COMPOSITIONS FOR REDUCING FACIAL LINES AND WRINKLES - A dietary supplement composition comprising a therapeutically effective amount of at least one sirt 1 activating agent, a therapeutically effective amount of at least one Qi activating agent, and an therapeutically effective amount of at least one adaptogen is disclosed. An optional herbal treatment for stress-related deep wrinkles comprises chronic oral administration for at least two weeks of a beverage containing an effective amount of a valerian root extract sufficient to provide a desired reduction in the appearance of the deep wrinkles. A photoprotective agent may also be included. Also included are a microcirculation increasing agent. Also optional are an herbal toner and topical cellulite product. | 2010-07-15 |
20100178287 | USE OF COAGULATION PROTEINS TO LYSE CLOTS - The present invention relates to the use of coagulation proteins for the lysis of blood clots. More specifically, the present invention provides a method for accelerating the dissolution of a blood clot through the administration of at least one coagulation protein comprising a basic C-terminal amino acid, wherein the coagulation protein may be a derivative of Factor X, Factor V or a combination thereof. Pharmaceutical compositions for the treatment and prophylaxis of blood clots are also provided, wherein, the methods and products of the present invention advantageously accelerate clot dissolution while potentially minimizing the adverse side-effects, such as hemorrhaging, seen with other clot dissolving agents. The present invention also provides a method for detecting a fibrinolytic potential in a subject. | 2010-07-15 |
20100178288 | USE OF APHANAMIXIS POLYSTACHA EXTRACTS OR FRACTIONS AGAINST 5-LIPOXYGENASE MEDIATED DISEASES - The invention discloses 5-lipoxygenase inhibitory product prepared from botanical sources. More specifically, the invention describes 5-lipoxygenase inhibitory extracts or bio-enriched extracts or fractions of | 2010-07-15 |
20100178289 | THERAPEUTIC USE OF IgG AS A NEUROPROTECTIVE AGENT - The present invention relates to compositions containing IgG and methods for the promotion of nerve regeneration or prevention or inhibition of neuronal degeneration by IgG to ameliorate the effects of injury, disorder or disease of the nervous system. | 2010-07-15 |
20100178290 | Methods for reducing viral load in HIV-1 infected patients - This invention provides a method of reducing viral load in an HIV-1-infected human subject which comprises administering to the subject an effective HIV-1 viral load reducing dose of a CCR5 receptor antagonist, such as a humanized antibody designated PRO 140 or an anti-CCR5 receptor monoclonal antibody, wherein the viral load reducing dose achieves an average maximum decrease of viral load in the subject of at least 1.83 log | 2010-07-15 |
20100178291 | Pyrrolidinone, Pyrrolidine-2, 5-Dione, Pyrrolidine and Thiosuccinimide Derivatives, Compositions and Methods for Treatment of Cancer - The present invention relates to pyrrolidin-2-one, pyrrolidin-2,5-dione, pyrrolidine and thiosucciniroide compounds of formulae (I)-(IV), and methods of preparation of these compounds. The present invention also relates to pharmaceutical compositions comprising pyrrolidin-2-one, pyrrolidin-2,5-dione, pyrrolidine and thiosuccinimide compounds. The present invention provides methods of treating a cell proliferative disorder, such as a cancer, by administering to a subject in need thereof a therapeutically effective amount of a compound of pyrrolidin-2-one, pyrrolidin-2,5-dione, pyrrolidine and thiosuccinimide compound of the present invention. | 2010-07-15 |
20100178292 | CRYPTIC GLYCAN MARKERS AND APPLICATIONS THEREOF - The present invention relates to a novel glycan marker of cancer and monoclonal antibodies against it. Furthermore, novel glycan markers and their use in the detection and monitoring of cancerous cells and cancer-associated or specific antibody signatures are described. | 2010-07-15 |
20100178293 | USE OF ANTIBODIES AGAINST THE CD52 ANTIGEN FOR THE TREATMENT OF NEUROLOGICAL DISORDERS, PARTICULARLY TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY AND ALZHEIMER'S DISEASE - The present invention relates to the use of antibodies against the CD52 antigen, specifically monoclonal antibodies, for the production of medicaments for the treatment of diseases of the central nervous system, in particular transmissible spongiform encephalopathies, diseases that are also called prion diseases. | 2010-07-15 |
20100178294 | MACROCYCLIC BETA-SECRETASE INHIBITORS - Disclosed are novel compounds of the formula | 2010-07-15 |
20100178295 | COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF INFLUENZA - The present invention provides novel human anti-influenza antibodies and related compositions and methods. These antibodies are used in the diagnosis and treatment of influenza infection. | 2010-07-15 |
20100178296 | ANTIBODIES TO CD200R - The present invention relates to binding compounds specific for the human inhibitory CD200R and uses thereof. More specifically, the invention relates to antibodies that recognize the human inhibitory CD200R and modulates its activity in inflammatory and autoimmune disorders. | 2010-07-15 |
20100178297 | Means and methods for the recruitment and identification of stem cells - Described are methods of modulating stem/progenitor cell recruitment involving molecules that agonize the formation of plasmin stimulating the recruitment of stem/progenitor cells, including hematopoietic and endothelial precursor cells. Conversely, antagonists of plasmin can inhibit recruitment of the stem cells. In addition, the identification of the uPA receptor (uPAR) as a retention signal for stem cells in their niche suggests a novel method for increased engraftment and isolation of multipotent stem cells. | 2010-07-15 |
20100178298 | Destruction of Tumor Cells by Trifunctional Bispecific Antibodies With Low to Medium Expression Levels of Tumor-Associated Target Antigens - The present invention describes the use of trifunctional bispecific antibodies for the preparation of a pharmaceutical composition for the prophylaxis and treatment of tumor diseases. It has been found that said trifunctional bispecific antibodies are binding to tumor-associated antigens selected from Her2/neu, CD20, EpCAM, G250, proteoglycans, GD3, GD2, MHC II, EGF-R and CEA, wherein said tumor-associated antigens are expressed on said tumor cell with a low to medium expression level only. | 2010-07-15 |
20100178299 | METHODS AND COMPOSITIONS FOR IMPROVING IMMUNE RESPONSES - The present invention relates to compositions and methods for enhancing an immune response, for example to a vaccine, by combining the administration of oxygen (O | 2010-07-15 |
20100178300 | CLAY INTERLACED YEAST COMPOSITIONS AND METHODS OF UTILIZING THE SAME - The present invention relates to compositions comprising yeast cells and/or yeast cell components and methods for producing and utilizing the same. In particular, the invention provides novel yeast comprising altered cell wall structure (e.g., clay and/or clay component(s) integrated (e.g., interlaced) into cell wall(s) and/or cell wall(s) comprising altered glucan:mannan ratio), methods of producing the same, compositions comprising and/or derived from the same, and methods of using the same (e.g., to sequester and/or adsorb bacteria and toxins). Compositions and methods of the invention find use in a variety of applications including dietary (e.g., admixing with feedstuffs or otherwise feeding to animals), therapeutic, prophylactic (e.g. admixing with bedding sources and/or other materials that come into contact with animals, usage during food and beverage processing and manufacture, and usage during filtration of liquids) as well as research applications. | 2010-07-15 |
20100178301 | METHOD OF TREATING PREGNANT COWS AND/OR HEIFERS - The present invention relates to combination vaccines for the prophylaxis and treatment of microbiological infections in cattle which comprise an attenuated bovine viral diarrhea virus (BVDV) for the the prophylaxis and treatment of BVDV caused infections. The invention also relates to a method of vaccinating a pregnant cow. | 2010-07-15 |
20100178302 | CHRONIC PATHOGEN-EXPRESSING CELL LINES - This application provides a method to establish and construct cell lines expressing pathogens without destruction of the host cells. The invention allows for the formation of cell lines for the purpose of continuous expression, release, and harvesting of the pathogen and maintaining the consistency of the final biological product. Although the invention is intended for pathogen antigen expression, the invention allows for the production of any antigen by the described methods. The establishment of a chronically infected cell line can be used for reagent, diagnostic, quantification, or vaccine purposes. We have used the procedure to select for a host cell line that naturally adapts to HIV-1 replication without affecting the host cell's ability to survive. This allowed for the establishment of a chronic HIV-1 expressing cell line that continuously expresses HIV-1 particles. | 2010-07-15 |
20100178303 | STABLE ORGANIC-CARRIER-BASED MICROBIAL INOCULANTS AND METHOD FOR PRODUCING THE SAME - The present invention relates to methods for producing microbial preparations for crop production and microbial preparations produced through such methods. The formulations contain microbial inoculants like | 2010-07-15 |
20100178304 | METHOD FOR SILK FIBROIN GELATION USING SONICATION - This invention provides for a process of rapidly forming silk fibroin gelation through ultrasonication. Under the appropriate conditions, gelation can be controlled to occur within two hours after the ultrasonication treatment. Biological materials, including viable cells, or therapeutic agents can be encapsulated in the hydrogels formed from the process and be used as delivery vehicles. | 2010-07-15 |
20100178305 | ULTRASONIC NANOTHERAPY OF SOLID TUMORS WITH BLOCK COPOLYMERS STABILIZED PERFLUOROCARBON NANODROPLETS - Described herein are methods of treating a tumor by contacting the tumor with a therapeutic agent encapsulated in a first nanoemulsion and exposing the tumor to a first ultrasonic radiation of less than 300 kHz to the tumor. In some aspects, the tumor can be contacted with a second nanoemulsion. In some aspects, the second emulsion can be injected directly into the tumor via intratumoral injection before exposing the tumor to the first ultrasonic radiation. In some aspects, the tumor is exposed to a second ultrasonic radiation from about 1 to 5 MHz after the first ultrasonic radiation. The methods described herein can be used to treat numerous tumors including, but not limited to, multidrug resistant tumors and inoperable tumors. These tumors may include, but are not limited to, breast cancers, ovarian cancers, pancreatic cancers, or any combination thereof. | 2010-07-15 |
20100178306 | PHARMACEUTICAL FORMULATION FOR THE PRODUCTION OF RAPIDLY DISINTEGRATING TABLETS - Pharmaceutical formulation in the form of agglomerates comprising | 2010-07-15 |
20100178307 | TRANSDERMAL ANTI-DEMENTIA ACTIVE AGENT FORMULATIONS AND METHODS FOR USING THE SAME - Transdermal anti-dementia active agent systems are provided. Aspects of systems include a transdermal preparation, first overlay and second overlay. Also provided are methods of using the systems, e.g. for administering an anti-dementia active agent to a subject. | 2010-07-15 |
20100178308 | SURFACE-MODIFIED (EFFECT) PIGMENTS - The invention relates to pigment based on (multiple) coated platelet-shaped substrates comprising an outer layer which is obtained by treatment with a metal oxide/hydroxide and then a phosphate ester, or phosphonate, or a salt thereof, with the proviso that the phosphate ester, or phosphonate do not contain fluorine, to a method for producing said pigments and the use thereof. The outer layer provides a very good photo-stabilisation of the TiO | 2010-07-15 |
20100178309 | METHOD FOR PRODUCTION OF RESIN PARTICLE - Disclosed is a method for producing resin particles, which can impart a desired function to the surface of resin particles efficiently and simply. Also disclosed are resin particles produced by the method. | 2010-07-15 |
20100178310 | AQUEOUS FORMULATION AND PROCESS FOR THE IMPREGNATION OF NON-LIVING-MATERIALS IMPARTING A PROTECTIVE ACTIVITY AGAINST PESTS - A formulation for the impregnation of non-living-materials, preferably textile materials, comprising at least a pesticide and a polymeric binder comprising as monomers at least ethylene and an unsaturated carboxylic acid, process for impregnating such materials and the use of such impregnated materials as mosquito-nets and for the protection of plants and other goods. | 2010-07-15 |
20100178311 | IMPLANT AND METHOD FOR ITS MANUFACTURE - The invention is directed to an implant ( | 2010-07-15 |
20100178312 | System And Method For Attaching Soft Tissue To An Implant - One embodiment of the present invention is directed to compositions and methods for enhancing attachment of soft tissues to a metal prosthetic device. In one embodiment a construct is provided comprising a metal implant having a porous metal region, wherein said porous region exhibits a nano-textured surface, and a biocompatible polymer matrix coating the nano-textured surface. The polymer matrix coating comprises a naturally occurring extracellular matrix with biocompatible inorganic materials distributed within the matrix, or a biocompatible polymer and an osteoinductive agent. | 2010-07-15 |
20100178313 | Implantable Degradable Biopolymer Fiber Devices - Degradable fibers that include biopolymers, as well as implantable devices including one or more fibers made from degradable biopolymers, e.g., alginate, chitosan, hyaluronans or their derivatives. The devices provide a combination of degradability and biocompatibility with physical properties suitable for use of the devices as implants. Exemplary devices are fastening devices including one or more biopolymer fibers. The use of such degradable biopolymers minimizes or eliminates the need for a second surgery to remove the implant, thereby eliminating the additional cost and potential complications of such a second surgery and should reduce the likelihood of secondary fractures resulting from the stress-shielding effect or the presence of screws holes that serve as stress concentrators. Methods for the fabrication of the degradable biopolymer fibers of the present invention are also provided, as well as methods for the fabrication of implantable degradable devices of the present invention which contain one or more degradable biopolymer fibers. | 2010-07-15 |